QIAGEN (QGEN) announced that the German Federal Patent Court has ruled in its favor in a patent dispute against SD ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court ...

Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while ...

Neurizon Therapeutics has achieved a key milestone with a patent granted in the US for its lead drug candidate NUZ-001 to ...

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...

If Trump’s prior presidential term serves as any indication of what is to come, we can expect to see several significant ...

Neurizon (ASX:NUZ) has officially snagged a U.S. patent for its neurodegenerative disease and cancer drug candidate NUZ-001, ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

A well-known Greek philosopher during 400 BCE once said: "The only true wisdom is in knowing you know nothing." This holds ...

The upside to this war of words? More competition is boosting consumer choice, including with OpenAI’s release over the weekend of a new AI model, o3-mini.

The Motion Pictures Association (MPA), representing top entertainment companies such as Netflix, Disney, Amazon, and Sony, is supporting a new U.S. bill aimed at cracking down on foreign piracy ...

The new sorghum varieties provide a climate-smart alternative grain for food science, breweries and dairy farmers ...